Conexeu Sciences Inc. (CNXU) News
Track canonical SquawkNews coverage tagged to CNXU, Conexeu Sciences Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 6 indexed stories across 4 publication days and is ordered by the same first-publication timeline used by LiveCast.
H
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Liminatus Pharma (NASDAQ: LIMN ) stock increased by 40.9% to $0.16 during Thursday's pre-market session. The market value of their outstanding shares is at $5.8 million. Stablecoin Development (AMEX: SDEV ) stock
EARNINGS | Jul 02, 2026, 12:05 PM UTC
L
CNXU Opens R&D Facility
Conexeu Sciences opens Vancouver R&D facility to advance regenerative tissue platform
EQUITY | Jun 25, 2026, 12:31 PM UTC
M
Banks Initiate Coverage
Multiple banks initiate coverage on various stocks with different ratings
EQUITY | Jun 23, 2026, 10:55 AM UTC
M
CRDO: Credo Initiated
Credo Technology Group Holding Ltd initiated with Outperform rating and $325 price target by Evercore ISI Group analyst Mark Lipacis
EQUITY | Jun 22, 2026, 12:39 PM UTC
M
CNXU: HC Wainwright Initiates Buy
HC Wainwright & Co. initiates coverage on Conexeu Sciences with a buy rating and a price target of $20
EQUITY | Jun 22, 2026, 11:00 AM UTC
M
Banks Initiate Coverage
Multiple banks initiate coverage on various stocks with different ratings
EQUITY | Jun 22, 2026, 10:57 AM UTC